Market by Animal Type, Disease Type, Product Type, and Country Outlook | Forecast 2022-2028
As per Triton’s
research report, the veterinary vaccines market in the Asia-Pacific is
estimated to grow with a CAGR of 8.79%
over the forecasting period 2022-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries analyzed in this region include:
•       Â
China
•       Â
India
•       Â
Japan
•       Â
South Korea
•       Â
ASEAN Countries
•       Â
Australia & New Zealand
•       Â
Rest of Asia-Pacific
Asia accounts for the highest
population of livestock, such as pigs, cattle, fish, and poultry, which makes
it an attractive market, having plenty of opportunities for veterinary vaccine
manufacturers. Also, the enhanced focus in this region by domestic as well as
international market players in terms of investments, R&D facilities, manufacturing
facilities, and so on, acts as driving factors for the APAC’s veterinary
vaccine market.
In Malaysia, the
concept of pet humanization has increased dramatically in the past few years.
There is a high rate of adoption of cats and dogs across the country. Several
pet care organizations around the nation are also working on various programs
to promote pet adoption. For example, Voice For Paws conducts adoption drives
in the capital city of Kuala Lumpur. Thus, the vast pet population and their
high adoption rate are expected to promote the veterinary vaccines market
growth in the ASEAN country.
Meanwhile, the Rest of
Asia-Pacific region consists of countries that are agricultural economies, where
farm animals such as dairy cows, beef cattle, goats, sheep, etc., are used for
different purposes such as to obtain dairy or meat products. Any deterioration in
the animals’ health due to disease can cost these economies heavily. The high
reliance on livestock for food production makes it important to take care of
them. This presents an opportunity to the players in the veterinary vaccines market
in Rest of Asia-Pacific to capitalize on.
Cattle are used for multiple
purposes, ranging from farming to consumption. They play a vital role in terms
of food consumption in the form of dairy and meat products. As they live in a group
or herd, cattle are prone to diseases. Therefore, there is a chance of the disease
spreading from one animal to the other, and, thereby, to the whole herd. Vaccination
is a must to avoid this problem. The most commonly found cattle diseases are
black quarter disease, anthrax disease, rinderpest, foot-and-mouth disease,
etc. The studied report assesses the
market’s growth based on animal type, disease type, and product type. Here,
the animal type segment comprises livestock animals, companion animals, and aquaculture.
The livestock animals sub-segment includes cattle, poultry, pigs, sheep, and
other livestock animals.
Leading
companies considered in the veterinary vaccines market include Indian
Immunologicals Limited, Merck Animal Health, Zoetis Inc, Hester Biosciences
Ltd, Brilliant Bio Pharma, and Phibro Animal Health.
Hester Biosciences Ltd
is a renowned animal health company. It operates in verticals like animal
vaccines, poultry vaccines, animal health products, and poultry health products.
Additionally, Hester also offers services such as diagnostic labs &
seroprofiling kits for poultry flocks and mastitis control programs for cattle.
The India-based company was founded in 1987 and is headquartered in Ahmedabad, Gujarat.
Hester is the first company in the country to manufacture goat pox vaccine and
also its second-largest poultry vaccine manufacturer. It enjoys economies of
scale owing to its massive production capacity.
Â
Â
Key deliverables of the report:
·     Â
Market
CAGR during the forecasting years 2022-2028
·     Â
Detailed
data highlighting key insights, industry components, and market strategies
·     Â
Comprehensive
information and estimation of the veterinary vaccines market revenue growth in
Asia-Pacific and its influence on the parent market
·     Â
In-depth
study of forthcoming trends in consumer behavioral patterns
·     Â
A
meticulous analysis of the competitive landscape, vendor scorecard, and
Porter’s Five Forces
·     Â
A
wide-ranging study of factors that will challenge the APAC veterinary vaccines
market’s growth during the upcoming years
Want
to get specific insights? Our team of analysts can customize this report based
on your preferences. Connect with us here.Â
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
VETERINARY VACCINES MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE VETERINARY VACCINES MARKET
2.2. KEY
INSIGHTS
2.2.1. INCREASING
INNOVATION BY MARKET PARTICIPANTS
2.2.2. ADVANCEMENTS
IN VACCINE AND DIAGNOSTIC TECHNOLOGY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VALUE
CHAIN ANALYSIS
2.6. KEY
BUYING CRITERIA
2.7. REGULATORY
FRAMEWORK
2.8. VENDOR
SCORECARD
2.9. KEY
MARKET STRATEGIES
2.9.1. MERGERS
& ACQUISITIONS
2.9.2. CONTRACTS
& AGREEMENTS
2.9.3. PRODUCT
LAUNCHES
2.9.4. EXPANSIONS
& DIVESTITURES
2.10. MARKET
DRIVERS
2.10.1. HIGH
VACCINE DEMAND DUE TO INCREASING ANIMAL POPULATION AND DISEASES
2.10.2. GOVERNMENT-ORGANIZED
VACCINATION DRIVESÂ Â Â Â Â Â
2.10.3. ADVANCED
VACCINE RESEARCH AND DEVELOPMENT
2.11. MARKET
CHALLENGES
2.11.1. LACK
OF AWARENESS AND SCARCITY OF SKILLED VETERINARIANS
2.11.2. STRINGENT
RULES AND REGULATIONS PERTAINING TO VACCINE USE
2.12. MARKET
OPPORTUNITIES
2.12.1. EXPANSION
OF THE ANIMAL HEALTHCARE MARKET IN THE ASIA-PACIFIC
2.12.2. RISING
DEMAND FOR COMPANION ANIMALS
3. ASIA-PACIFIC
VETERINARY VACCINES MARKET OUTLOOK – BY ANIMAL TYPE
3.1. LIVESTOCK
ANIMALS
3.1.1. CATTLE
3.1.2. PIGS
3.1.3. POULTRY
3.1.4. SHEEP
3.1.5. OTHER
LIVESTOCK ANIMALS
3.2. COMPANION
ANIMALS
3.2.1. CANINE
3.2.2. FELINE
3.2.3. EQUINE
3.3. AQUACULTURE
4. ASIA-PACIFIC
VETERINARY VACCINES MARKET OUTLOOK – BY DISEASE TYPE
4.1. CANINE
DISEASE
4.2. PORCINE
DISEASE
4.3. BOVINE
DISEASE
4.4. POULTRY
DISEASE
4.5. AQUACULTURE
DISEASE
4.6. OTHER
DISEASE TYPE
5. ASIA-PACIFIC
VETERINARY VACCINES MARKET OUTLOOK – BY PRODUCT TYPE
5.1. ATTENUATED
VACCINES
5.2. INACTIVATED
VACCINES
5.3. TOXOID
VACCINES
5.4. CONJUGATE
VACCINES
5.5. DNA
VACCINES
5.6. RECOMBINANT
VACCINES
5.7. SUBUNIT
VACCINES
6. ASIA-PACIFIC
VETERINARY VACCINES MARKET – COUNTRY OUTLOOK
6.1. CHINA
6.2. JAPAN
6.3. INDIA
6.4. SOUTH
KOREA
6.5. ASEAN
COUNTRIES
6.6. AUSTRALIA
& NEW ZEALAND
6.7. REST
OF ASIA-PACIFIC
7. COMPETITIVE
LANDSCAPE
7.1. BOEHRINGER
INGELHEIM INTERNATIONAL GMBH
7.2. BRILLIANT
BIO PHARMA
7.3. CEVA
SANTE ANIMALE
7.4. ELANCO
ANIMAL HEALTH INC
7.5. HESTER
BIOSCIENCES LTD
7.6. HIPRA
7.7. INDIAN
IMMUNOLOGICALS LIMITED
7.8. MERCK
ANIMAL HEALTH
7.9. PHIBRO
ANIMAL HEALTH
7.10. VAXXINOVA
GMBH
7.11. VIRBAC
SA
7.12. ZOETIS
INC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: VENDOR SCORECARD
TABLE 4: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC VETERINARY
VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE
1: MARKET ATTRACTIVENESS INDEX
FIGURE
2: VALUE CHAIN ANALYSIS
FIGURE
3: KEY BUYING CRITERIA
FIGURE
4: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2021 & 2028 (IN
%)
FIGURE
5: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN
$ MILLION)
FIGURE
6: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2021 &
2028 (IN %)
FIGURE
7: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY CATTLE, 2022-2028 (IN $ MILLION)
FIGURE
8: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY PIGS, 2022-2028 (IN $ MILLION)
FIGURE
9: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY POULTRY, 2022-2028 (IN $
MILLION)
FIGURE
10: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY SHEEP, 2022-2028 (IN $ MILLION)
FIGURE
11: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY OTHER LIVESTOCK ANIMALS,
2022-2028 (IN $ MILLION)
FIGURE
12: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028
(IN $ MILLION)
FIGURE
13: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2021 &
2028 (IN %)
FIGURE
14: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY CANINE, 2022-2028 (IN $ MILLION)
FIGURE
15: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY FELINE, 2022-2028 (IN $
MILLION)
FIGURE
16: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY EQUINE, 2022-2028 (IN $
MILLION)
FIGURE
17: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY AQUACULTURE, 2022-2028 (IN $
MILLION)
FIGURE
18: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2021 & 2028
(IN %)
FIGURE
19: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2022-2028 (IN $
MILLION)
FIGURE
20: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2022-2028 (IN
$ MILLION)
FIGURE
21: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2022-2028 (IN $
MILLION)
FIGURE
22: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2022-2028 (IN
$ MILLION)
FIGURE
23: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2022-2028
(IN $ MILLION)
FIGURE
24: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2022-2028
(IN $ MILLION)
FIGURE
25: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2021 & 2028
(IN %)
FIGURE
26: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY ATTENUATED VACCINES, 2022-2028
(IN $ MILLION)
FIGURE
27: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY INACTIVATED VACCINES, 2022-2028
(IN $ MILLION)
FIGURE
28: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY TOXOID VACCINES, 2022-2028 (IN
$ MILLION)
FIGURE
29: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY CONJUGATE VACCINES, 2022-2028
(IN $ MILLION)
FIGURE
30: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY DNA VACCINES, 2022-2028 (IN $
MILLION)
FIGURE
31: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINES, 2022-2028
(IN $ MILLION)
FIGURE
32: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY SUBUNIT VACCINES, 2022-2028 (IN
$ MILLION)
FIGURE
33: ASIA-PACIFIC VETERINARY VACCINES MARKET, COUNTRY OUTLOOK, 2021 & 2028
(IN %)
FIGURE
34: CHINA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE
35: JAPAN VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE
36: INDIA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE
37: SOUTH KOREA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE
38: ASEAN COUNTRIES VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE
39: AUSTRALIA & NEW ZEALAND VETERINARY VACCINES MARKET 2022-2028 (IN $
MILLION)
FIGURE
40: REST OF ASIA-PACIFIC VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)